- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03762889
Peri-operative Application of Eyeprotx General Anesthesia Goggles As Prevention Against Corneal Injury Post Intubation.
Peri-operative Application of EYEPROTX General Anesthesia Protective Goggles as an Effective Modality to Reduce the Incidence of Corneal Injury Post-Intubation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Ocular injury is but a devastating condition that can occur perioperatively under general anesthesia. Corneal abrasion is the most common ocular injury during general anesthesia, surpassing case incidence of damage caused by patient movement in ophthalmologic surgery. Causes of ocular injury include corneal drying due to the suppression of tear ducts from anesthetic agents, direct physical trauma, or agitation from the volatile anesthetic used. Ocular injury may also occur due to bacterial infection with MRSA, preventative methods, or rubbing of the eyes postoperatively due to agitation. Agitation may be caused by corneal drying or by shift or disruption in rapid eye movement sleep cycle from light penetration through the eyelids. Attempts at prevention of corneal abrasion have been used, including taping the eyelids shut, manual eye closure, paraffin-based ointment application into the conjunctival sac, and the use of hydrophilic contact lenses, although only a few studies have validated the comparison of these methods' effectiveness.
Eyeprotx™ Protective Goggles have been designed specifically for use in the operating room or in any scenario where general anesthesia must be used, such as intubation in an emergency. Current ocular protective measures such as tapes during anesthesia have been associated with injury and infection. With this study, we hope to find a safer preventative technique against ocular injury during the perioperative period.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- Jackson Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients undergoing general anesthesia
- Patients admitted to Jackson Memorial Hospital
Exclusion Criteria:
- Patients unable to communicate, for whatever reason
- Patients predisposed to eye conditions
- Patients with history of increased intraocular pressure
- Patients with a medical history of Sicca syndrome
- Patients with claustrophobia
- Patients with pseudoexfoliation syndromes
- Patients with a current exopthalmic condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Eyeprotx™ Group
This group of participants will use the Eyeprotx™ General Anesthesia Protective Goggles when intubated perioperatively under general anesthesia.
|
Eyeprotx™ Protective Goggles have been designed specifically for use in the operating room or in any scenario where general anesthesia must be used, such as intubation in an emergency.
The integral function is to reduce intraocular pressure while in place, prevent operating room bright light penetration, facilitate a swift placement preventative measure with straps, form a barrier against bacterial invasion and mechanical damage.
This study would seek to examine this goggles' effectiveness as a preventative measure as vs. other measures.
|
Active Comparator: Eyelid Tape Group
This group of participants will be receiving the eyelid tape as the preventative measure when intubated perioperatively under general anesthesia.
|
Taping the eyelids during intubation is one of the standard techniques used perioperatively under general anesthesia.
This intervention would be used for the Eyelid Tape Group.
|
Active Comparator: Eye Ointment Group
This group of participants will be receiving the ointment application when intubated perioperatively under general anesthesia.
|
Another standard technique used perioperatively under general anesthesia is to apply an ointment to the eye for lubrication.
This intervention would be applied to the Eye Ointment Group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Baseline Ocular Condition post-operatively
Time Frame: The patient's initial rating will be recorded approximately ten minutes before surgery at the point of anesthesia evaluation and will be reassessed up to 24 hours post-operatively.
|
The following will be measured upon evaluation, using a numerical scale of 1 to 8, with 1 being complete absence of condition and 8 being the most severe presentation of the condition: 1. eye discomfort, 2, pain, and 3. dryness intensity, each on a numerical rating-scale of 1 to 8, The measures will be compared among the goggle, ointment, and tape groups. |
The patient's initial rating will be recorded approximately ten minutes before surgery at the point of anesthesia evaluation and will be reassessed up to 24 hours post-operatively.
|
Incidence of Ocular Complications post-operation
Time Frame: Evaluation of these complications will be done from the point the patient has returned to the recovery room to up to one week post-surgery or until discharge, whichever comes first.
|
Incidence of corneal abrasion, conjunctivitis, MRSA infection, and direct ocular trauma will be assessed by the anesthesiologist or nurse anesthetist and will be recorded upon diagnosis of condition for all groups.
|
Evaluation of these complications will be done from the point the patient has returned to the recovery room to up to one week post-surgery or until discharge, whichever comes first.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Awareness during Anesthesia
Time Frame: This measure will be evaluated up to 48 hours post-surgical operation.
|
Patient awareness of being under anesthesia will be recorded qualitatively, with accounts of anxiety and/or fear being noted, if applicable.
|
This measure will be evaluated up to 48 hours post-surgical operation.
|
Incidence of Nightmare during Use
Time Frame: This measure will be evaluated up to 48 hours post-surgical operation.
|
Patient's report of experiencing nightmares during the surgery will be recorded qualitatively.
|
This measure will be evaluated up to 48 hours post-surgical operation.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Usability Scale Per Operator
Time Frame: This measure will be evaluated up to 6 months after the post-surgical operation.
|
The anesthesiologists and nurse anesthetists working on the trial will be asked to complete a usability scale questionnaire to evaluate the effectiveness of the different variation of the goggles, such as goggles with a strap versus goggles with short sterilized adhesive tape.
|
This measure will be evaluated up to 6 months after the post-surgical operation.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Adam M Au, DO MD PHD, Jackson Health System
Publications and helpful links
General Publications
- Gild WM, Posner KL, Caplan RA, Cheney FW. Eye injuries associated with anesthesia. A closed claims analysis. Anesthesiology. 1992 Feb;76(2):204-8. doi: 10.1097/00000542-199202000-00008.
- Figueiro MG, Rea MS. Preliminary evidence that light through the eyelids can suppress melatonin and phase shift dim light melatonin onset. BMC Res Notes. 2012 May 7;5:221. doi: 10.1186/1756-0500-5-221.
- White E, Crosse MM. The aetiology and prevention of peri-operative corneal abrasions. Anaesthesia. 1998 Feb;53(2):157-61. doi: 10.1046/j.1365-2044.1998.00269.x.
Helpful Links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20180875
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Injuries
-
Medical University of ViennaCompletedCorneal Infiltrates | Corneal AbrasionsAustria
-
University Hospital, Strasbourg, FranceTerminatedKeratitis | Pterygium | Corneal Perforation | Corneal Opacity Corneal ThinningFrance
-
Tianjin Eye HospitalRecruitingCorneal Perforation, Corneal Stromal Lenticule,Sandwich TechniqueChina
-
Claris Biotherapeutics, Inc.RecruitingCorneal ScarUnited States
-
L.V. Prasad Eye InstituteUnknownCorneal Injuries | Corneal Scars and Opacities | Corneal BurnsIndia
-
Centro Hospitalar de Vila Nova de Gaia/Espinho,...CompletedNeurotrophic Keratitis | Corneal Ulcer | Corneal Perforation | Corneal Epithelium DefectPortugal
-
L.V. Prasad Eye InstituteNot yet recruiting
-
University Hospital, MontpellierUnknownCorneal Diseases | Keratoconus | Corneal Ulcer | Corneal Trauma | Corneal DystrophiesFrance
-
L.V. Prasad Eye InstituteUnknownCorneal Scars and OpacitiesIndia
-
Mayo ClinicTerminatedCorneal AbrasionUnited States
Clinical Trials on Eyeprotx™ General Anesthesia Protective Goggles
-
University of Vermont Medical CenterNot yet recruitingObesity | Surgery | Anesthesia | Mechanical Ventilation | Echocardiography, TransesophagealUnited States
-
AcelRx Pharmaceuticals, Inc.Completed
-
Children's Hospital of PhiladelphiaCompletedCongenital Cystic Adenomatoid MalformationUnited States
-
AcelRx Pharmaceuticals, Inc.CompletedModerate-to-severe Acute PainUnited States
-
Hartford HospitalRecruiting
-
Attikon HospitalRecruitingIntraoperative AnalgesiaGreece
-
Otsuka Pharmaceutical, Inc., PhilippinesCompletedNSAID Induced GastropathyPhilippines
-
BioDelivery Sciences InternationalCompletedPain | CancerUnited States
-
AcelRx Pharmaceuticals, Inc.Completed
-
AcelRx Pharmaceuticals, Inc.Completed